PROVENGE (sipuleucel-T)

For the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/30Rlx2K